Chemed
(NYSE:CHE)
$565.52
-2.85[-0.50%]
At close: May 17
$565.52
0[0.00%]
After Hours: 4:04PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$712.00
Lowest Price Target1
$579.00
Consensus Price Target1
$647.00

Chemed Stock (NYSE:CHE), Analyst Ratings, Price Targets, Predictions

Chemed Corp has a consensus price target of $647, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Oppenheimer, and Oppenheimer on March 4, 2024, February 29, 2024, and January 17, 2024. With an average price target of $662.33 between RBC Capital, Oppenheimer, and Oppenheimer, there's an implied 17.12% upside for Chemed Corp from these 3 analyst ratings.

Analyst Trend
1
Jan
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Oppenheimer
RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Chemed

Buy NowGet Alert
03/04/2024Buy Now25.9%RBC Capital
Ben Hendrix
$604 → $712MaintainsOutperformGet Alert
02/29/2024Buy Now14.94%Oppenheimer
Michael Wiederhorn
$625 → $650MaintainsOutperformGet Alert
01/17/2024Buy Now10.52%Oppenheimer
Michael Wiederhorn
$590 → $625MaintainsOutperformGet Alert
10/30/2023Buy Now6.8%RBC Capital
Ben Hendrix
$576 → $604MaintainsOutperformGet Alert
07/31/2023Buy Now1.85%RBC Capital
Ben Hendrix
$610 → $576MaintainsOutperformGet Alert
07/27/2023Buy Now4.33%Oppenheimer
Michael Wiederhorn
$610 → $590MaintainsOutperformGet Alert
05/01/2023Buy Now7.87%RBC Capital
Ben Hendrix
$587 → $610MaintainsOutperformGet Alert
04/28/2023Buy Now7.87%Oppenheimer
Michael Wiederhorn
$580 → $610MaintainsOutperformGet Alert
02/27/2023Buy Now3.8%RBC Capital
Ben Hendrix
$545 → $587MaintainsOutperformGet Alert
11/03/2022Buy Now-3.63%RBC Capital
Ben Hendrix
$541 → $545MaintainsOutperformGet Alert
08/01/2022Buy Now-4.34%RBC Capital
Ben Hendrix
$592 → $541MaintainsOutperformGet Alert
04/28/2022Buy Now4.68%RBC Capital
Ben Hendrix
$579 → $592MaintainsOutperformGet Alert
03/04/2022Buy Now2.38%RBC Capital
Frank Morgan
$609 → $579MaintainsOutperformGet Alert
07/29/2021Buy Now7.69%RBC Capital
Frank Morgan
MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Chemed (CHE)?

A

The latest price target for Chemed (NYSE: CHE) was reported by RBC Capital on March 4, 2024. The analyst firm set a price target for $712.00 expecting CHE to rise to within 12 months (a possible 25.90% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Chemed (CHE)?

A

The latest analyst rating for Chemed (NYSE: CHE) was provided by RBC Capital, and Chemed maintained their outperform rating.

Q

When was the last upgrade for Chemed (CHE)?

A

There is no last upgrade for Chemed.

Q

When was the last downgrade for Chemed (CHE)?

A

There is no last downgrade for Chemed.

Q

When is the next analyst rating going to be posted or updated for Chemed (CHE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemed was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.

Q

Is the Analyst Rating Chemed (CHE) correct?

A

While ratings are subjective and will change, the latest Chemed (CHE) rating was a maintained with a price target of $604.00 to $712.00. The current price Chemed (CHE) is trading at is $565.52, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch